PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8 + T Cells by Bowers, Jacob S, Majchrzak, Kinga, Nelson, Michelle H, Aksoy, Bulent Arman, Wyatt, Megan M, Smith, Aubrey S, Bailey, Stefanie R, Neal, Lillian R, Hammerbacher, Jeffrey E, Paulos, Chrystal M

Get full text

T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy by Yamamoto, Tori N, Lee, Ping-Hsien, Vodnala, Suman K, Gurusamy, Devikala, Kishton, Rigel J, Yu, Zhiya, Eidizadeh, Arash, Eil, Robert, Fioravanti, Jessica, Gattinoni, Luca, Kochenderfer, James N, Fry, Terry J, Aksoy, Bulent Arman, Hammerbacher, Jeffrey E, Cruz, Anthony C, Siegel, Richard M, Restifo, Nicholas P, Klebanoff, Christopher A

Get full text

Anti-CTLA4 activates intratumoral NK cells and combination with IL15/IL15Rα complexes enhances tumor control by Sanseviero, Emilio, O’Brien, Erin M., Karras, Jenna R., Shabaneh, Tamer B., Aksoy, B. Arman, Xu, Wei, Zheng, Cathy, Yin, Xiangfan, Xu, Xiaowei, Karakousis, Giorgos, Amaravadi, Ravi, Nam, Brian T., Turk, Mary Jo, Hammerbacher, Jeffrey E., Schuchter, Lynn, Mitchell, Tara C., Liu, Qin, Stone, Erica L.

Get full text

Abstract A005: A phase I study of the safety and immunogenicity of a multipeptide personalized genomic vaccine in the adjuvant treatment of solid cancers by Blazquez, Ana B., Rubinsteyn, Alex, Kodysh, Julia, Finnigan, John P., Marron, Thomas, Sabado, Rachel L., Meseck, Marcia, O'Donnell, Timothy J., Hammerbacher, Jeffrey, Donovan, Michael, Holt, John, Mahajan, Milind, Mandeli, John, Misiukiewicz, Krysztof, Genden, Eric M., Milles, Brett A., Khorasani, Hooman, Dottino, Peter R., Irie, Hanna, Tiersten, Amy B., Port, Elisa R., Wolf, Andrea S., Cho, Hern J., Tewari, Ashutosh, Parekh, Samir S., Nair, Sujit, Galsky, Matthew D., Oh, William K., Gnjatic, Sacha, Schadt, Eric E., Friedlander, Phillip A., Bhardwaj, Nina

Get full text